Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for NexGel, Inc. (NXGL : NSDQ)

• Company Description    NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa. Number of Employees: 19

• Price / Volume Information    Yesterday's Closing Price: $2.62 Daily Weekly Monthly 20 Day Moving Average: 41,242 shares Shares Outstanding: 7.65 (millions) Market Capitalization: $20.06 (millions) Beta: 0.59 52 Week High: $5.10 52 Week Low: $1.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 14.41% 9.70% 12 Week -1.50% -13.69% Year To Date -41.26% -44.52%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2150 Cabot Blvd West Suite B - LANGHORNE,PA 19047 USA ph: 215-702-8550 fax: - valter@kcsa.com https://nexgel.com

• General Corporate Information    Officers Adam Levy - Chief Executive Officer and President Joseph F. McGuire - Chief Financial Officer Steven Glassman - Director Scott Henry - Director Nachum Stein - Director Peer Information NexGel, Inc. (ABMD) NexGel, Inc. (DMDS) NexGel, Inc. (CPWY.) NexGel, Inc. (EQUR) NexGel, Inc. (ECIA) NexGel, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 65344E107 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/18/25 Share - Related Items Shares Outstanding: 7.65 Most Recent Split Date: (:1) Beta: 0.59 Market Capitalization: $20.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.60 Price/Cash Flow: - Price / Sales: 1.96 EPS Growth vs. Year Ago Period: 35.71% vs. Previous Quarter: -12.50% Sales Growth vs. Year Ago Period: 121.64% vs. Previous Quarter: -7.73% ROE 06/30/25 - - 03/31/25 - -54.95 12/31/24 - -58.62 ROA 06/30/25 - - 03/31/25 - -27.84 12/31/24 - -29.23 Current Ratio 06/30/25 - - 03/31/25 - 1.88 12/31/24 - 2.07 Quick Ratio 06/30/25 - - 03/31/25 - 1.15 12/31/24 - 1.36 Operating Margin 06/30/25 - - 03/31/25 - -28.42 12/31/24 - -35.09 Net Margin 06/30/25 - - 03/31/25 - -30.80 12/31/24 - -37.88 Pre-Tax Margin 06/30/25 - - 03/31/25 - -31.64 12/31/24 - -39.86 Book Value 06/30/25 - - 03/31/25 - 0.73 12/31/24 - 0.90 Inventory Turnover 06/30/25 - - 03/31/25 - 3.78 12/31/24 - 3.75 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.15 12/31/24 - 0.15 Debt-to-Capital 06/30/25 - - 03/31/25 - 13.32 12/31/24 - 12.83

Powered by Zacks Investment Research ©